Compounds > colforsin
Page last updated: 2024-08-23

colforsin and Multiple Myeloma

colforsin has been researched along with Multiple Myeloma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blomhoff, HK; Follin-Arbelet, V; Misund, K; Naderi, EH; Sundan, A; Torgersen, ML1
Blomhoff, HK; Follin-Arbelet, V; Misund, K; Naderi, EH; Sundan, A; Ugland, H1
Blomhoff, HK; Blomhoff, R; Bogen, B; Follin-Arbelet, V; Hauglin, H; Hofgaard, PO; Naderi, S; Sundan, A1
Halgren, RG; Krett, NL; Pillay, S; Rosen, ST; Traynor, AE; Zell, JL1
Li, Y; Shen, B; Song, J1
Katagiri, M; Kawabata, I; Shibata, T1

Other Studies

6 other study(ies) available for colforsin and Multiple Myeloma

ArticleYear
Death of multiple myeloma cells induced by cAMP-signaling involves downregulation of Mcl-1 via the JAK/STAT pathway.
    Cancer letters, 2013, Jul-28, Volume: 335, Issue:2

    Topics: Apoptosis; Cell Line, Tumor; Colforsin; Cyclic AMP; Down-Regulation; Humans; Interleukin-6; Janus Kinase 1; Multiple Myeloma; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; STAT3 Transcription Factor; Syndecan-1

2013
The natural compound forskolin synergizes with dexamethasone to induce cell death in myeloma cells via BIM.
    Scientific reports, 2015, Aug-26, Volume: 5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Cell Line, Tumor; Colforsin; Dexamethasone; Dose-Response Relationship, Drug; Drug Synergism; Humans; Membrane Proteins; Multiple Myeloma; Proto-Oncogene Proteins; Treatment Outcome

2015
Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model.
    BMC cancer, 2011, Jul-18, Volume: 11

    Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Colforsin; Cyclic AMP; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Intracellular Space; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Multiple Myeloma; Poly(ADP-ribose) Polymerases; Thionucleotides; Time Factors; Tumor Burden

2011
Cyclic adenosine-3',5'-monophosphate-mediated cytotoxicity in steroid sensitive and resistant myeloma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Bucladesine; Butyrates; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dexamethasone; Drug Resistance, Neoplasm; Enzyme Activation; Glucocorticoids; Humans; Interleukin-6; Multiple Myeloma; Tumor Cells, Cultured; Tumor Stem Cell Assay

1997
[Activation of PKA pathway inhibits reactivity of human myeloma cell line-U266 to IL-6].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2001, Volume: 23, Issue:4

    Topics: CCAAT-Enhancer-Binding Protein-beta; Cell Division; Colforsin; Cyclic AMP-Dependent Protein Kinases; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Interleukin-6; Multiple Myeloma; Signal Transduction; STAT3 Transcription Factor; Trans-Activators; Tumor Cells, Cultured

2001
[Analysis of the regulation of HLA class II genes by forskolin].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1992, Volume: 67, Issue:3

    Topics: Colforsin; Cyclic AMP; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens Class II; HLA-DQ Antigens; HLA-DR Antigens; Humans; Multiple Myeloma; Transcription, Genetic; Tumor Cells, Cultured

1992